22 March
KLC Law Firm is proud to have supported (Specifar) Teva in the divestment of its Greek manufacturing site to PharmaPath.
KLC Law Firm is proud to have supported (Specifar) Teva in the divestment of its Greek manufacturing site to PharmaPath. We have successfully addressed together with the experienced Teva team the complexities of this transaction in order to get to a smooth closing, ensuring uninterrupted operation of the site. This transaction provides further evidence of the established presence and expertise of KLC in the Greek pharmaceutical sector and enhances its track record with one more notable transaction.
In regards to real estate technical matters, KLC was supported by PL Surveyors+Consultants, a boutique technical advisory firm with in-depth knowledge of the technical prerequisites related to real estate transactions.